— Know what they know.
Not Investment Advice

AKLI NASDAQ

Akili, Inc.
1W: -0.6% 1M: +2.7% 3M: +66.2% 1Y: -61.1%
$0.43
Last traded 2024-07-02 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services · $34.1M mcap · 23M float · 9.16% daily turnover

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$2M +419.5% ▲
4Y CAGR: -46.2%
Gross Profit
$859K +828.0% ▲
4Y CAGR: -53.7%
Operating Income
-$64M +28.9% ▲
Net Income
-$59M -647.0% ▼
EPS (Diluted)
$-0.76 -660.0% ▼
EBITDA
-$57M +32.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$20M$4M$538K$323K$2M
YoY Growth+0.0%-80.3%-86.3%-40.0%+419.5%
Cost of Revenue$1M$416K$355K$441K$819K
Gross Profit$19M$4M$183K-$118K$859K
Gross Margin93.3%89.4%34.0%-36.5%51.2%
R&D Expenses$21M$15M$18M$29M$20M
SG&A Expenses$19M$14M$43M$62M$45M
Operating Expenses$40M$29M$61M$91M$65M
Operating Income-$21M-$25M-$61M-$91M-$64M
Operating Margin-107.6%-645.7%-11286.1%-28073.4%-3843.0%
Interest Expense$157K$333K$465K$1M$2M
Income Before Tax-$21M-$26M-$61M-$8M-$59M
Tax Expense$13K$1K$482K$19K$0
Net Income-$21M-$26M-$62M-$8M-$59M
Net Margin-103.2%-651.1%-11492.6%-2465.6%-3545.5%
EPS (Diluted)$-0.27$-0.33$-0.79$-0.10$-0.76
EBITDA-$20M-$25M-$60M-$6M-$57M
Shares Outstanding78M78M78M78M78M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms